Joint Fellowship Training Program
Program 4
Cancer Prevention Fellows
First Year Curricula and Responsibilities
Individuals will pursue a master's degree in clinical investigation (M.S.) or in public health (M.P.H). Those already possessing a master's degree, will come directly to the NCI/FDA and begin the activities described below.
Second Through Fourth Year Curricula and Responsibilities
Fellows will pursue research and training at NCI and FDA. At the NCI fellows will participate in the NCI's Summer Curriculum in Cancer Prevention, Molecular Prevention Laboratory, weekly Fellows Research Meetings and Colloquia series, Grants and Grantsmanship Workshop, Effective Presentations Workshop, and other professional development activities.
At the FDA, depending upon research interests, fellows will choose from among the product or clinical divisions of the participating FDA Centers. In a particular product division, fellows interested in regulatory research and related regulatory experience will work with a principal investigator or branch chief (or designee) selected through mutual agreement. Fellows may elect to work in a product division or in a pharmacology/toxicology branch in a clinical division. Both clinical and non-clinical fellows will have the option of performing translational research in the participating division, branch, or office.
Fellows will participate in various regulatory activities of the division at the FDA where they undertake their research. Fellows will spend approximately 40% of their time in product, pharmacology/toxicology, or clinical reviews and policy and guidance document development. They will participate in grand rounds and meetings related to regulatory activities. Additionally, fellows will attend courses offered by the participating FDA Centers and pass required testing in reviewer training.
Fellows' performance will be evaluated by Fellowship Program staff at the NCI and FDA, research mentors, and scientific staff overseeing fellows' activities at either institution.
